Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0948265 (
metabolic syndrome
)
24,271
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PPARgamma and pRB play an important role in the development of adipose cells, and functional modification of these proteins may lead to beneficial changes in adipose cell physiology. In the present work, we show that over-expression of
EID1
(E1A-like inhibitor of differentiation), an inhibitor of muscle cell differentiation, reduces PPARgamma ligand-dependent transactivation and decreases triglyceride stores in pre-adipocytes (3T3-L1 cells). Additionally, we found that
EID1
binds to pRB at the onset of adipocyte differentiation and may act to reduce pRB levels. Over-expression of
EID1
in 3T3-L1 cells leads to increased expression of UCP1 and PGC-1alpha, both of which are involved in caloric dissipation and thermogenesis, in brown adipose tissue. These results indicate that
EID1
is able to reduce fat accumulation in adipose cells and induce expression of brown fat genes in pre-adipocytes (3T3-L1 cells) normally destined to become white fat cells. The functional reduction of PPARgamma and pRB mediated by
EID1
in adipose cells may play an important role in insulin resistance and the
metabolic syndrome
.
...
PMID:EID1-induces brown-like adipocyte traits in white 3T3-L1 pre-adipocytes. 2054 31